A new study released in March found that many men receiving prostate specific antigen (PSA) testing do so without a comprehensive shared decision-making process, contrary to current guidelines. The American Cancer Society study, appearing in Annals of Family Medicine, finds that in both 2010 and 2015 about six in 10 men who reported recent PSA testing said they had received at least one component of shared decision making with their healthcare providers. Meanwhile, only 1 in 10 with no PSA test reported receiving any component of shared decision making in both 2010 and 2015.
